A Research Study Investigating the Efficiency of Experimental Crenolanib With Chemotherapy in Patients With Acute Myeloid Leukemia
You are being asked to take part in this study because you have acute myeloid leukemia even though you had previous treatment(s).
- for people ages 18-75 (full criteria)
- at UC Davis
- study startedestimated completion
Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Fludarabine Cytarabine Mitoxantrone Idarubicin Crenolanib G-CSF
- accepting new patients
- Start Date
- Completion Date
- Arog Pharmaceuticals, Inc.
- Phase 3
- Study Type
- Last Updated